Petcoil, Inc.

Petcoil, Inc., a for-profit medical imaging technology manufacturer based in Sunnyvale, California, develops portable, high-resolution positron emission tomography (PET) scanner systems for neurological and head-and-neck imaging applications, working as a federal grant recipient (50% of recent awards) and as a sub-recipient on National Institutes of Health research programs. The company has no federal contract prime awards or contract vehicles; its federal engagement consists entirely of NIH Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) grants and grant sub-awards.

Petcoil's customer footprint is concentrated within the National Institutes of Health. All eight recent awards span four NIH institutes: the National Institute of Biomedical Imaging and Bioengineering (4 awards), the National Institute of Mental Health (2 awards), the National Institute of Dental and Craniofacial Research (1 award), and the National Institute of Neurological Disorders and Stroke (1 award). As a prime grant recipient, Petcoil holds a $409,779 Phase I SBIR award from the National Institute of Dental and Craniofacial Research (CFDA 93.121, Oral Diseases and Disorders Research) authorized July 1, 2026, for development of a real-time motion correction method for a portable, high-resolution time-of-flight PET scanner designed for head-and-neck cancer imaging, with ultimate completion June 30, 2027. The company also holds a $1.4 million Commercialization Readiness Project grant from the National Institute of Mental Health authorized March 11, 2025, for optimization of a portable PET insert system capable of simultaneous time-of-flight PET and MRI brain imaging, running through February 29, 2028. As a sub-recipient, Petcoil works under The Leland Stanford Junior University on four grant sub-awards (dating April 9, 2024, through July 8, 2025), developing image reconstruction workstation software, DICOM-adherent image conversion, PACS integration, and quality-assurance procedures for the Stanford-led PET insert platform.

Activity shows light volume with episodic clustering: two awards in 2020, a two-year gap, two awards in 2024, three awards in 2025, and one in 2026. The company obligated $13.3 million across all eight awards. Two awards face ultimate completion within the next twenty-four months. Petcoil's core capability is the design, prototyping, and commercialization of brain-dedicated PET insert systems that integrate with existing MRI platforms at 10-fold lower cost than permanently integrated whole-body PET/MRI systems, with superior spatial resolution and photon sensitivity for neurological and oncological diagnostic imaging. The company competes in the NIH SBIR/STTR ecosystem rather than in federal contract vehicles and carries no SBA set-aside designations across recent award history.